Selected research
Market Outlook & Growth Opportunities
Global In Vivo PK Services Market Outlook and Growth Opportunities 2026
Market perspective
The global In Vivo PK Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for In Vivo PK Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for In Vivo PK Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In Vivo PK Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the In Vivo PK Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the In Vivo PK Services market include Microconstants, SCYNEXIS ADMET, Frontage, Drug Development Solutions, Altasciences, NorthEast BioLab, Eurofins, BioPharma Services and Smithers, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global In Vivo PK Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of In Vivo PK Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents In Vivo PK Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global In Vivo PK Services market.
In Vivo PK Services Segment by Company
Microconstants
SCYNEXIS ADMET
Frontage
Drug Development Solutions
Altasciences
NorthEast BioLab
Eurofins
BioPharma Services
Smithers
Pacific BioLabs
Accelera
SGS
In Vivo PK Services Segment by Type
Biological Sample Development
Biological Sample Verification
Biological Sample Testing
In Vivo PK Services Segment by Application
Hospital
Clinic
Research Institutions
In Vivo PK Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global In Vivo PK Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the In Vivo PK Services key companies, revenue, market share, and recent developments.
3. To split the In Vivo PK Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions In Vivo PK Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify In Vivo PK Services significant trends, drivers, influence factors in global and regions.
6. To analyze In Vivo PK Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vivo PK Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vivo PK Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vivo PK Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vivo PK Services industry.
Chapter 3: Detailed analysis of In Vivo PK Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of In Vivo PK Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of In Vivo PK Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Sample Development
- Biological Sample Verification
- Biological Sample Testing
Applications
- Hospital
- Clinic
- Research Institutions
Companies covered
- Microconstants
- SCYNEXIS ADMET
- Frontage
- Drug Development Solutions
- Altasciences
- NorthEast BioLab
- Eurofins
- BioPharma Services
- Smithers
- Pacific BioLabs
- Accelera
- SGS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global In Vivo PK Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global In Vivo PK Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 In Vivo PK Services Market Dynamics
- 2.1 In Vivo PK Services Industry Trends
- 2.2 In Vivo PK Services Industry Drivers
- 2.3 In Vivo PK Services Industry Opportunities and Challenges
- 2.4 In Vivo PK Services Industry Restraints
3 In Vivo PK Services Market by Company
- 3.1 Global In Vivo PK Services Company Revenue Ranking in 2025
- 3.2 Global In Vivo PK Services Revenue by Company (2021-2026)
- 3.3 Global In Vivo PK Services Company Ranking (2024-2026)
- 3.4 Global In Vivo PK Services Company Manufacturing Base and Headquarters
- 3.5 Global In Vivo PK Services Company Product Type and Application
- 3.6 Global In Vivo PK Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global In Vivo PK Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 In Vivo PK Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 In Vivo PK Services Market by Type
- 4.1 In Vivo PK Services Type Introduction
- 4.1.1 Biological Sample Development
- 4.1.2 Biological Sample Verification
- 4.1.3 Biological Sample Testing
- 4.2 Global In Vivo PK Services Sales Value by Type
- 4.2.1 Global In Vivo PK Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global In Vivo PK Services Sales Value by Type (2021-2032)
- 4.2.3 Global In Vivo PK Services Sales Value Share by Type (2021-2032)
5 In Vivo PK Services Market by Application
- 5.1 In Vivo PK Services Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Research Institutions
- 5.2 Global In Vivo PK Services Sales Value by Application
- 5.2.1 Global In Vivo PK Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global In Vivo PK Services Sales Value by Application (2021-2032)
- 5.2.3 Global In Vivo PK Services Sales Value Share by Application (2021-2032)
6 In Vivo PK Services Regional Value Analysis
- 6.1 Global In Vivo PK Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global In Vivo PK Services Sales Value by Region (2021-2032)
- 6.2.1 Global In Vivo PK Services Sales Value by Region: 2021-2026
- 6.2.2 Global In Vivo PK Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America In Vivo PK Services Sales Value (2021-2032)
- 6.3.2 North America In Vivo PK Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe In Vivo PK Services Sales Value (2021-2032)
- 6.4.2 Europe In Vivo PK Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific In Vivo PK Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific In Vivo PK Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America In Vivo PK Services Sales Value (2021-2032)
- 6.6.2 South America In Vivo PK Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa In Vivo PK Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa In Vivo PK Services Sales Value Share by Country, 2025 VS 2032
7 In Vivo PK Services Country-level Value Analysis
- 7.1 Global In Vivo PK Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global In Vivo PK Services Sales Value by Country (2021-2032)
- 7.2.1 Global In Vivo PK Services Sales Value by Country (2021-2026)
- 7.2.2 Global In Vivo PK Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt In Vivo PK Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt In Vivo PK Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt In Vivo PK Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Microconstants
- 8.1.1 Microconstants Company Information
- 8.1.2 Microconstants Business Overview
- 8.1.3 Microconstants In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Microconstants In Vivo PK Services Product Portfolio
- 8.1.5 Microconstants Recent Developments
- 8.2 SCYNEXIS ADMET
- 8.2.1 SCYNEXIS ADMET Company Information
- 8.2.2 SCYNEXIS ADMET Business Overview
- 8.2.3 SCYNEXIS ADMET In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.2.4 SCYNEXIS ADMET In Vivo PK Services Product Portfolio
- 8.2.5 SCYNEXIS ADMET Recent Developments
- 8.3 Frontage
- 8.3.1 Frontage Company Information
- 8.3.2 Frontage Business Overview
- 8.3.3 Frontage In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Frontage In Vivo PK Services Product Portfolio
- 8.3.5 Frontage Recent Developments
- 8.4 Drug Development Solutions
- 8.4.1 Drug Development Solutions Company Information
- 8.4.2 Drug Development Solutions Business Overview
- 8.4.3 Drug Development Solutions In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Drug Development Solutions In Vivo PK Services Product Portfolio
- 8.4.5 Drug Development Solutions Recent Developments
- 8.5 Altasciences
- 8.5.1 Altasciences Company Information
- 8.5.2 Altasciences Business Overview
- 8.5.3 Altasciences In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Altasciences In Vivo PK Services Product Portfolio
- 8.5.5 Altasciences Recent Developments
- 8.6 NorthEast BioLab
- 8.6.1 NorthEast BioLab Company Information
- 8.6.2 NorthEast BioLab Business Overview
- 8.6.3 NorthEast BioLab In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.6.4 NorthEast BioLab In Vivo PK Services Product Portfolio
- 8.6.5 NorthEast BioLab Recent Developments
- 8.7 Eurofins
- 8.7.1 Eurofins Company Information
- 8.7.2 Eurofins Business Overview
- 8.7.3 Eurofins In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Eurofins In Vivo PK Services Product Portfolio
- 8.7.5 Eurofins Recent Developments
- 8.8 BioPharma Services
- 8.8.1 BioPharma Services Company Information
- 8.8.2 BioPharma Services Business Overview
- 8.8.3 BioPharma Services In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.8.4 BioPharma Services In Vivo PK Services Product Portfolio
- 8.8.5 BioPharma Services Recent Developments
- 8.9 Smithers
- 8.9.1 Smithers Company Information
- 8.9.2 Smithers Business Overview
- 8.9.3 Smithers In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Smithers In Vivo PK Services Product Portfolio
- 8.9.5 Smithers Recent Developments
- 8.10 Pacific BioLabs
- 8.10.1 Pacific BioLabs Company Information
- 8.10.2 Pacific BioLabs Business Overview
- 8.10.3 Pacific BioLabs In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Pacific BioLabs In Vivo PK Services Product Portfolio
- 8.10.5 Pacific BioLabs Recent Developments
- 8.11 Accelera
- 8.11.1 Accelera Company Information
- 8.11.2 Accelera Business Overview
- 8.11.3 Accelera In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Accelera In Vivo PK Services Product Portfolio
- 8.11.5 Accelera Recent Developments
- 8.12 SGS
- 8.12.1 SGS Company Information
- 8.12.2 SGS Business Overview
- 8.12.3 SGS In Vivo PK Services Revenue and Gross Margin (2021-2026)
- 8.12.4 SGS In Vivo PK Services Product Portfolio
- 8.12.5 SGS Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst